Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$5.42 - $7.08 $58,731 - $76,718
-10,836 Reduced 29.51%
25,884 $373 Million
Q1 2025

May 15, 2025

BUY
$5.26 - $8.55 $1,157 - $1,881
220 Added 0.6%
36,720 $253 Million
Q4 2024

Feb 12, 2025

BUY
$3.25 - $7.72 $118,625 - $281,780
36,500 New
36,500 $194 Million

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Integrated Quantitative Investments LLC Portfolio

Follow Integrated Quantitative Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Quantitative Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Quantitative Investments LLC with notifications on news.